FDA premarket records place GM Dos Reis Industria e Comercio Ltda. as the legal applicant behind orthopedic intramedullary nail filings, with a Campinas, São Paulo address used in regulatory correspondence. The supplied filings show two distinct device lines: the DuoCore Non-Compressive IM Nail, cleared in late 2026, and the GMReis Fibula Nail System, cleared in 2025. Company-level registration data published by the FDA lists the firm under its own establishment registration, separate from the product clearances themselves. [1][3][8]

The DuoCore clearance and its scope

The supplied record sample contains one 510(k): K263241 for the DuoCore Non-Compressive IM Nail, received September 16, 2026 and decided November 2, 2026 as substantially equivalent under decision code SESE. The FDA record lists product code HWC, regulation number 888.3040, device class 2, orthopedic advisory committee, and a Special clearance type with a summary statement. The applicant of record is GM Dos Reis Industria e Comercio Ltda., with a Campinas address and Brazil country code. [1]

The instructions for use published by the firm describe the DuoCore Non-Compressive IM Nail as a single-use product, supplied non-sterile or sterile, with non-sterile implants requiring cleaning and sterilization before use and reprocessing prohibited. The same document lists a size designation of Ø4,0x80,0mm alongside a set of instruments, including guide wires, cannulated drills, T6 and T8 wrenches with depth gauges, threaded nail extractors and a disposable wrench with AO coupling. [2]

The Fibula Nail System filing

An FDA clearance letter dated June 12, 2025 addresses K250559 for the GMReis Fibula Nail System, citing regulation 21 CFR 888.3020, intramedullary fixation rod, class II, product code HSB, with a submission dated February 25, 2025 and received May 27, 2025. The letter is addressed to Guilherme Esteves Pontes, identified as Senior Regulatory Affairs Analyst, at the Campinas address. The accompanying summary names GM Dos Reis Industria e Comercio as submitter and lists the common name as rod, fixation, intramedullary and accessories. [8]

The Fibula Nail System instructions for use describe a system of locked intramedullary nails for osteosynthesis of fibular fractures, offered in multiple lengths and diameters and supplied non-sterile. The product code table lists left fibula nails in 3,0mm and 3,6mm diameters across 110mm, 145mm and 180mm lengths. The document carries a caution that federal law restricts the device to sale by or on the order of a physician. [5][7]

Registration and corporate identifiers

The FDA establishment registration and device listing database shows GM DOS REIS INDUSTRIA E COMERCIO LTDA at Avenida Pierre Simon de La Place, 600, Campinas, Sao Paulo, with registration number 3013756169, FEI number 3013756169 and active status. This registration entry is a separate record type from the 510(k) clearances and does not by itself establish manufacturing scope for any specific device. [3]

Brazil's Portal da Transparência lists the legal entity under registration number 60.040.599/0001-19, opened February 14, 1989, with legal nature 2062, Sociedade Empresária Limitada, and CNAE 32507 for manufacture of instruments and materials for medical and dental use and optical articles, at Avenida Pierre Simon de Laplace, 600, Techno Park, Campinas, SP. The Fibula Nail instructions for use carry the same tax ID, 60.040.599/0001-19, alongside the Campinas address and contact details. [6][7]

Identifiers and labeling details

A GUDID record for primary DI 07901125621831 covers the DuoCore Non-Compressive IM Nail, model 395-25-14, described as Ø2,5x14,0mm, published November 5, 2026, with distribution status in commercial distribution, sterile false, single use true, prescription true and no MRI safety information in the labeling. The same record associates the brand with product code HWC, screw, fixation. [4]

The public documents do not document ownership by a parent company, a brand relationship beyond the GMReis naming used on the Fibula Nail System documents, customer lists, sales figures or post-market safety performance. The collection counts in the supplied filings describe only the records retrieved as of the snapshot date and are not a measure of total company portfolio or commercial activity. [1][3][8]